Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
about
Purinergic Signaling in Gut Inflammation: The Role of Connexins and PannexinsThe Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseInflammatory bowel disease: an increased risk factor for neurologic complicationsRelationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndromePeripheral changes in endometriosis-associated pain.The arachidonic acid metabolite 11β-ProstaglandinF2α controls intestinal epithelial healing: deficiency in patients with Crohn's disease.Neuroinflammation in inflammatory bowel disease.Use of biological molecules in the treatment of inflammatory bowel disease.The vagal innervation of the gut and immune homeostasisThe severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.Protective effect of melatonin on myenteric neuron damage in experimental colitis in rats.A role for interleukin 17A in IBD-related neuroplasticity.Autonomic nervous system function predicts the inflammatory response over three years in newly diagnosed ulcerative colitis patients.Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?Case report showing that a woman with ulcerative colitis refractory to standard therapy responded well to the sympathomimetic amine dextroamphetamine sulfate.Altered Salivary Alpha-Amylase Secretion in Patients with Ulcerative Colitis.
P2860
Q26738433-1A3AECB8-796A-42B2-B720-E551F963B345Q26774660-8129A515-C1FA-4283-92DD-22A606A05D7FQ27690759-2A867362-7822-4511-ADC2-DFBE3F697FF3Q34160082-1865D4F5-9244-4CC3-A641-E0BC65E0426EQ34421299-7FC61DEF-EA54-4855-BD0F-8166708882C7Q36860041-2BB2F3B6-5EA6-41CC-A11F-52D1EE245548Q37771058-A4F83E56-1504-415D-963D-07075B34A8FDQ37829470-7BE120A7-9FC6-4947-B2F7-07873DC432B9Q38047774-0A259F36-FB74-42C8-B6BD-D9ACC98AE0F8Q40830748-3393E580-D2B3-4EB3-8248-1366C4DED117Q48258834-026FD675-68A4-4440-84DE-7E3096CBA55CQ48353162-2C52D015-0270-4298-BA68-F7BBEF291BFAQ51751141-53833E5C-9F6D-4811-8B20-ECA17E149E85Q52589926-C252AEA0-94CC-4B59-BD51-452809B3214AQ53846328-C9E7CBA3-91D2-43BF-A975-B77935B30705Q55440505-C96D5B4C-8694-44CD-8588-F3950346AE7D
P2860
Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and experimental evid ...... ng inflammatory bowel disease.
@en
Clinical and experimental evid ...... ng inflammatory bowel disease.
@nl
type
label
Clinical and experimental evid ...... ng inflammatory bowel disease.
@en
Clinical and experimental evid ...... ng inflammatory bowel disease.
@nl
prefLabel
Clinical and experimental evid ...... ng inflammatory bowel disease.
@en
Clinical and experimental evid ...... ng inflammatory bowel disease.
@nl
P2093
P2860
P1476
Clinical and experimental evid ...... ing inflammatory bowel disease
@en
P2093
Lysa Boissé
Mark K Lukewich
Susan P Chisholm
P2860
P304
P356
10.1111/J.1440-1681.2009.05242.X
P577
2009-06-29T00:00:00Z